SIGNATURE ESTATE & INVESTMENT ADVISORS LLC
Position in ENTX — Entera Bio Ltd.
CIK 1079935
LOS ANGELES, CA
Position in ENTX
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$83,770
+$31,236 QoQ
Shares Held
47,328
0.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 27 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ENTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SIGNATURE ESTATE & INVESTMENT ADVISORS LLC holds $7,978,434 across 6 Biotechnology names. ENTX ranks #5 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
197,419 | $6,986,658 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
1,832 | $448,418 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
478 | $237,436 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
737 | $210,022 | |
| 5 | ENTX |
Entera Bio Ltd.
This page
|
47,328 | $83,770 | |
| 6 | INO |
Inovio Pharmaceuticals, Inc.
|
11,028 | $12,130 |
All Filings in ENTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,770 | 47,328 | Shares | Defined | 2026-07-14 | |
| 2026-03-31 | $52,534 | 47,328 | Shares | Defined | 2026-04-15 | |
| 2025-12-31 | $91,816 | 47,328 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $90,869 | 47,328 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $89,923 | 47,328 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $80,457 | 47,328 | Shares | Defined | 2025-05-16 | |
| 2024-12-31 | $100,335 | 47,328 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $89,923 | 47,328 | Shares | Defined | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||